|
2/24/2026 Comments Melanocyte–Fibroblast Crosstalk: From “brightening” to dermo‑epidermal tone orchestration across all prototypes RETHINKING PIGMENTARY AGING: FROM MELANIN LOAD TO MELANOCYTE-FIBROBLAST CROSS-TALK Melanocyte fibroblast crosstalk is central in pigmentary aging. This holds true across phototypes I to VI. It is particularly visible in darker skin where chronological and structural aging progress more slowly, yet pigmentary disorders dominate the clinical picture.¹⁻³ Fibroblasts mainly sit in the dermis. Melanocytes mainly sit above them in the epidermis. Fibroblasts send chemical messages to melanocytes. These messages tell melanocytes how active to be. They also influence how much pigment reaches the surface and how evenly it is distributed.⁴⁻⁸ Some messages dampen pigment production, for example DKK1. Other messages like Neuregulin 1 enhance pigment production. Together these signals shape baseline skin tone. They also shape how dark spots and uneven tone appear with age.⁴⁻⁷ With time and sun exposure fibroblasts and melanocytes change. Some become senescent. Senescent melanocytes use more glucose and produce more lactate. They transport pigment granules less efficiently. This contributes to mottled dark and light areas.¹⁰ ¹¹ Lighter skin tends to show early wrinkles and fine lines. Darker skin shows later wrinkling but more pronounced lentigines, post inflammatory hyperpigmentation and tone irregularities.¹⁻³ Structural aging is slower in darker phototypes. Pigmentary aging is relatively faster.¹⁻³ ¹² Future interventions should extend beyond lowering melanin synthesis alone. Classic tools such as tyrosinase inhibitors, antioxidants, hydroquinone, the original Kligman trio and newer triple combinations mainly reduce melanogenesis and accelerate epidermal pigment clearance. In addition, next‑generation strategies should rebalance fibroblast secretomes and dermo‑epidermal crosstalk and reduce senescence‑related stress in melanocytes. This systems‑level approach is relevant across all phototypes and is particularly critical in phototypes V and VI.⁸ ¹⁰ Let´s have a closer look......  Figure 1. DKK1 versus neuregulin 1 effects on epidermal pigmentation. Two schematic epidermal panels illustrate how high DKK1 is associated with small, weakly dendritic melanocytes, few melanosomes in keratinocytes, and a lighter epidermis, whereas high neuregulin 1 is associated with larger, highly dendritic melanocytes, abundant melanosomes in keratinocytes, and a darker epidermis. INTRODUCTION Cutaneous pigmentation depends on melanin synthesis within melanocytes, on melanosome biogenesis and transfer, and on the spatial distribution of pigment across the epidermis.¹³ Fitzpatrick phototypes I to VI capture broad differences in melanin quantity, melanosome size, and melanosome packaging.¹³ However these physical differences do not fully explain observed patterns of skin aging across ethnicities. Epidemiologic and clinical series show that individuals with phototypes I and II develop wrinkles and dermal laxity earlier and more severely than individuals with phototypes V and VI at comparable ages and environmental exposures.¹⁻³ In contrast darker phototypes exhibit a disproportionate prevalence of pigmentary conditions such as solar lentigines, melasma, post inflammatory hyperpigmentation and mottled dyschromia, despite comparatively preserved dermal structure and lower wrinkle scores.¹⁻³ ¹² This divergence suggests that regulation of pigment quality and distribution is at least as important as melanin load in shaping perceived skin aging. Dermal fibroblasts have emerged as key regulators of pigmentation. They do so through secretion of paracrine factors that influence melanocyte proliferation, dendricity, melanogenesis and melanosome transfer.⁴⁻⁸ ¹² A recent synthesis of data from melasma, solar lentigines, photoaging and vitiligo concluded that fibroblasts in hyperpigmented lesions secrete increased levels of melanogenesis promoting factors and altered extracellular matrix components, whereas fibroblasts in depigmented lesions tend to express higher levels of inhibitory or non supportive mediators.⁸ These findings place the fibroblast at the center of a pigment control network and may also be relevant for idiopathic guttate hypomelanosis, characterized by tiny white spots on sun exposed sites such as shins and forearms, for which I have been searching for effective appearance improving strategies for many years. In parallel, senescent melanocytes have been identified in chronically photoexposed skin. They display a distinct metabolic and secretory phenotype that can drive local pigmentary changes and paracrine inflammation.¹⁰ ¹¹ ¹⁴ Taken together, these observations support a dermo‑epidermal “tone orchestration” model in which the states of fibroblasts and melanocytes jointly shape pigmentary aging, with the final clinical picture amplified in a phototype specific manner. DERMAL SIGNALING TO MELANOCYTES DKK1 and Wnt β catenin DKK1 is a secreted inhibitor of the Wnt β catenin pathway. It is strongly expressed by palmoplantar fibroblasts, that is, fibroblasts from the palms of the hands and the soles of the feet. These regions are relatively hypopigmented and have thin epidermis.⁴ Yamaguchi and colleagues showed that DKK1 expression is higher in palmoplantar fibroblasts compared with non‑palmoplantar fibroblasts, and that recombinant (lab‑produced) DKK1 at one hundred nanograms per milliliter suppresses melanocyte proliferation and melanogenic protein expression. ⁴ In melanocytes DKK1 reduces tyrosinase (the key melanin‑producing enzyme), dopachrome tautomerase, Pmel17, MART 1 and MITF. It decreases β catenin and increases phosphorylated GSK3β.⁴ In reconstructed skin models DKK1 decreases melanin content and epidermal thickness. It also reduces melanosome transfer by downregulating PAR 2 in keratinocytes.⁴ These data provide a mechanistic explanation for the pale and thin phenotype of palmoplantar skin and illustrate the potency of a single fibroblast derived factor in modulating pigmentation. In vitiligo skin DKK1 expression is increased in lesional dermis. Exogenous DKK1 induces p16 expression in melanocytes and promotes senescence in vitro.¹⁵ This links DKK1 not only to hypopigmentation but also to melanocyte aging. Taken together these observations define DKK1 as a strong inhibitory paracrine signal that shapes local pigment patterns. This pattern suggests that long term high levels of DKK1 or similar inhibitory signals in small areas of the dermis could also help drive hypopigmented conditions such as idiopathic guttate hypomelanosis, by both slowing melanocyte activity and accelerating melanocyte aging in those spots.  Figure 2. Melanocyte–fibroblast crosstalk overview. Schematic cross‑section showing dermal fibroblast secretion of inhibitory DKK1 and pigment‑promoting factors (NRG1, SCF, ET‑1) toward basal melanocytes and how the net balance of these signals shifts visible skin tone. Neuregulin 1 SCF and endothelin 1 Neuregulin 1 is a fibroblast derived ligand ((a signaling molecule that binds a specific receptor) for ERBB receptors on melanocytes. It promotes melanocyte growth and differentiation. In skin equivalent models fibroblasts from darker skin express higher levels of neuregulin 1 and induce greater pigmentation than fibroblasts from lighter skin.⁶ ⁷ Supplementation of neuregulin 1 decreases L* values (makes the skin model appear darker on the color scale) by approximately one to three units in reconstructed epidermis, with the largest changes observed in dark skin models.⁶ Neuregulin 1 increases melanocyte size and dendricity and raises melanin content.⁶ ⁷ These effects demonstrate that baseline differences in fibroblast neuregulin 1 expression can account in part for interindividual and interethnic differences in constitutive pigmentation. The pathway seems to work in all phototypes. What changes is how strongly it is expressed. Fibroblasts also secrete stem cell factor, endothelin 1, hepatocyte growth factor and keratinocyte growth factor. These factors increase melanocyte proliferation, dendrite formation and melanogenesis in co culture and reconstructed skin models.⁵ ⁸ ¹² Conditioned media from fibroblasts taken from melasma or solar lentigo lesions raise tyrosinase activity and melanin content in melanocytes compared with media from nearby normal skin.⁵ ⁸ Together, these observations support a distinct lesional fibroblast (fibroblasts taken directly from the pigmented lesion) signature in acquired hyperpigmentation.  Figure 3. Metabolic reprogramming in senescent melanocytes. Cartoon comparison of a normal melanocyte and a senescent melanocyte, illustrating increased glucose uptake (≈2×) and lactate production (≈3.3×) in senescent cells, together with impaired melanosome transport and irregular pigment distribution in overlying keratinocytes. The emerging view is that a fibroblast melanogenic secretome, comprising neuregulin 1, stem cell factor, endothelin 1 and related cytokines, acts as a positive regulatory module. DKK1 and other Wnt antagonists act as negative regulators.⁴⁻⁸ ¹² Clinical pigmentation represents the net result of these opposing influences on a melanocyte network whose baseline activity is set by phototype. SENESCENT MELANOCYTES AND GLYCOLIC REPROGRAMMING Senescent melanocytes in photoexposed skin show durable cell cycle arrest and a senescence associated secretory phenotype.¹⁰ ¹¹ ¹⁴ A recent study developed a UV induced senescent melanocyte model. Transcriptomic and metabolic profiling revealed profound changes in energy metabolism.¹⁰ ¹¹ Senescent melanocytes consume approximately twice as much glucose as non senescent controls. They produce about three point three times more lactate.¹⁰ ¹¹ These shifts indicate strong glycolytic reprogramming. They resemble the Warburg effect described in other senescent and neoplastic cells. Functional analysis showed that senescent melanocytes exhibit melanosome transport dysfunction. Pigment granules accumulate in perinuclear regions and fewer reach distal dendrites and the surrounding keratinocytes.¹⁰ ¹¹ ¹⁴ This defect aligns with clinical observations of mottled hyperpigmented and hypopigmented macules in photoaged skin and may also contribute to the small, sharply demarcated hypopigmented macules seen in idiopathic guttate hypomelanosis, as a working hypothesis. In this sense, clusters of senescent melanocytes and fibroblasts create a hostile microenvironment for normal pigment homeostasis. Pharmacologic inhibition of glycolysis in this model reduced p16 and p21 expression. It attenuated senescence associated secretory phenotype markers. It partially restored melanosome transport.¹⁰ ¹¹ These findings demonstrate that metabolic state is causally linked to pigmentary dysfunction in senescent melanocytes.  Figure 4. Clinical emphasis of melanocyte–fibroblast crosstalk across phototype subgroups. Stylized faces for phototypes I–II, III–IV and V–VI highlight the dominant clinical features of aging (wrinkles vs pigment spots) and the corresponding emphasis of crosstalk pathways, from mainly structural aging in lighter phototypes to pigmentary aging in darker phototypes. Melanocyte density and melanosome content increase from phototypes I and II to phototypes V and VI.¹³ In darker phototypes a given fraction of melanocytes entering senescence affects a larger absolute pigment load. This may help explain the heavy burden of focal dyschromia seen in phototypes V and VI despite relative preservation of dermal architecture.¹⁻³ ¹² PHOTOAGED FIBROBLASTS AND PIGMENTARY FEEDBACK Fibroblasts from photoaged skin differ from those from young photo protected skin. They show: ▌ reduced collagen synthesis ▌ altered extracellular matrix remodelling ▌ increased expression of inflammatory mediators¹⁶ ▌ changes in pigment related signals In reconstructed skin models fibroblasts from photoaged facial skin induce darker epidermis than fibroblasts from young skin. Epidermal L* values are lower. Melanin content is higher. Expression of melanogenic genes is increased. These differences are statistically significant.⁵ ⁹ The findings indicate that age modified fibroblasts can drive and maintain hyperpigmentation. Single cell RNA sequencing of human dermis has defined multiple fibroblast subpopulations: papillary fibroblasts, reticular fibroblasts, secretory fibroblasts, pro inflammatory fibroblasts. Aging shifts the population toward secretory and inflammatory phenotypes.¹⁶ This is associated with decreased collagen gene expression and altered paracrine (changed cell‑to‑cell signaling via secreted factors) output. These changes are observed in skin from different ancestries. The qualitative direction appears conserved. The clinical manifestations vary with phototype. In phototypes I and II structural aging features, such as wrinkles and laxity, dominate. In phototypes V and VI pigmentary changes are more visually prominent relative to structural decline.¹⁻³ ⁸ ¹² This is consistent with shared molecular pathways acting within distinct baseline contexts. PHOTOTYPE SUBGROUPS I II II IV V VI A functional grouping into three phototype clusters is useful. It reflects common mechanisms with different amplification. Subgroup I and II includes very fair and fair skin. These types have low eumelanin content. They have fewer melanocytes. They have smaller and less dense melanosomes.¹³ They burn easily and wrinkle early. Aging is driven mainly by dermal matrix degradation and actinic damage. Pigmentary issues such as lentigines occur but are not usually the dominant aesthetic concern.¹ ³ ¹² ¹⁶ Subgroup III and IV includes intermediate skin tones. These types show both wrinkles and pigmentary issues. Melasma and solar lentigines are common.² ³ Fibroblast secretome changes contribute to these lesions. However the overall aging phenotype is mixed, with structural and pigmentary components of similar weight.² ⁸ ¹² Subgroup V and VI includes dark brown and black skin. These types have high melanocyte activity. They have large and densely packed melanosomes. They exhibit strong natural photoprotection and delayed wrinkling.¹⁻³ ¹³ They also show high prevalence of solar lentigines, post inflammatory hyperpigmentation and mottled tone with age.¹⁻³ ⁸ ¹² In this subgroup fibroblast secretome shifts and senescent melanocytes act upon a high capacity pigmentary system. Modest changes in DKK1, neuregulin 1, stem cell factor or endothelin 1 can produce clinically conspicuous tone alterations.⁴⁻⁸ ¹⁰ ¹¹ ¹⁴ Thus over time, these changes establish a hostile dermo‑epidermal environment for balanced pigmentation, favouring pigmentary aging over structural aging. FROM BRIGHTENING TO DERMO EPIDERMAL ORCHESTRATION Conventional “brightening” or “hyperpigmentation” strategies act mainly on melanocytes. They focus on inhibiting tyrosinase and downstream melanogenesis, while largely overlooking the roles of fibroblasts, cellular senescence and metabolism. The crosstalk model suggests a broader approach built on three complementary levers. First dermal secretome modulation. Peptides and botanical fractions can be selected or designed to influence fibroblast output. They may normalize neuregulin 1, stem cell factor and endothelin 1. They may tune Wnt related signalling and DKK1. The goal is restoration of balanced crosstalk rather than blunt suppression of pigmentation.⁵ ⁸ ¹² Second melanocyte focused modulation. Tyrosinase inhibitors, PAR 2 modulators and antioxidants remain central. They should be optimized for barrier compatibility and irritation control. This is particularly important in phototypes V and VI where post inflammatory hyperpigmentation risk is high and baseline melanogenesis is strong.⁴ ¹² ¹⁴ Third senescence informed strategies. Actives with senomorphic potential may reduce the senescence associated secretory phenotype without inducing excessive cell death. Examples include certain flavonoids, resveratrol like molecules and carotenoids.¹⁰ ¹¹ ¹⁴ They can be combined with metabolic support and antioxidant systems. They may help shift melanocytes away from a glycolysis high senescent state.  Figure 5. Multi target product concept based on dermo epidermal tone orchestration. A targeted skin tone therapy acts in parallel on fibroblast secretome balance, melanocyte melanin synthesis and transfer, and senescent cell SASP and metabolism, leading to a more even toned epidermis over a preserved dermis. For darker phototypes an optimal regimen would integrate these three layers. It would: ▌support dermal matrix integrity ▌normalize fibroblast messaging ▌stabilize melanocyte metabolism ▌reduce oxidative stress ▌modulate melanin synthesis and transfer in a controlled way ▌respect barrier integrity and minimize irritation This perspective is unique because it reframes “brightening” as dermo epidermal tone orchestration, links pigmentary aging to fibroblast secretomes and senescent melanocyte metabolism, and translates these mechanisms into concrete, phototype inclusive intervention levers. Take care! Anne-Marie References
This article is intended purely for education and reflection. It does not replace a consultation with your own dermatologist, physician or other qualified health professional, nor does it serve as diagnosis, treatment plan or product recommendation. Always discuss your individual skin concerns, conditions with a trusted medical expert who knows your history and can examine you in person.
Comments
|
CategoriesAll Acne Age Clocks Ageing Aquatic Wrinkles Armpits Autophagy Biostimulators Blue Light & HEVIS Circadian Rhythms Cleansing Collagen CoQ10 Cosmetic Intolerance Syndrome Couperose Deodorant Dermaplaning Diabetes DNA Damage DNA Repair Dry Skin Epigenetics Epigenome Evidence Based Skin Care Exfoliation Exosomes Exposome Eyes Face Or Feet? Facial Blushing Facial Flushing Facial Oils Ferroptosis Fibroblast Fingertip Units Gendered Ageism Genome Glycation Growth Factors Gua Sha Hair Hair Removal Hallmark Of Aging Healthy Skin Heat Shock Proteins Hormesis Humidity Hyaluron Hyaluronidase Hyperpigmentation Hypo-allergenic Idiopathic Gutatte Hypomelanosis (IGH) Indulging Inflammasome Interactome Jade Roller Keratinocytes Licochalcone A Lipid Peroxidation Luxury Skin Care Lymphatic Vessel Ageing Malar Oedema Matrikines Melasma Menopause Microbiome Milky Toners Mitochondrial Dysfunction Mood Boosting Skin Care Neurocosmetics Oily Skin Ox Inflammageing Peptides PH Balance Skin Photo Biomodulation Pigmentary Aging Polynucleotides Post-inflammatory Hyperpigmentation Proteasome Proteome Psoriasis Purging Regeneration Regenerative Treatments Review Rosacea Safety Scarring Sensitive Skin Skin Care Regimen Skin Flooding Skin Hydration Skin Senescence Skin Tone Evens Skip-Care Sleep Slugging Solar Lengtigines Spicules Sunscreen Tanning Under Eye Bags UV Index Vitamin C Vitamin D Well Ageing Skin Care Wound Healing Wrinkles
Archives
February 2026
|
RSS Feed